People
Champions Oncology expands bioanalytical services with new technology
8 January 2025 - Oncology research company Champions Oncology Inc (NASDAQ: CSBR) announced on Wednesday that it has enhanced its clinical bioanalytical services portfolio by integrating Cytek Aurora f...
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
12 December 2024 - Petauri, a US-based purpose-built pharmaceutical services platform, announced on Wednesday that Nicole Lodowski, managing director of Petauri Evidence, has been named as one of MM+M...
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
8 November 2024 - WuXi XDC Cayman Inc (HK: 2268), a China-based global CRDMO (Contract Research, Development, and Manufacturing Organisation) specialising in antibody-drug conjugates (ADCs) and other ...
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business
5 November 2024 - Nektar Therapeutics (Nasdaq: NKTR), a biotechnology company focused on the discovery and development of novel therapies to treat autoimmune disorders, announced on Monday that it has...
Insmed receives highest ranking in Science's 2024 Top Employers Survey
25 October 2024 - US-based biopharmaceutical company Insmed Incorporated (Nasdaq:INSM) announced on Thursday that it has received the highest ranking in Science journal's 2024 Top Employers Surve...
OncoZenge partners with Pharmanovia for exclusive BupiZenge commercialization in EMENA regions
18 October 2024 - Pharmaceutical company OncoZenge AB (publ) (STO:ONCOZ) announced on Friday plans to partner with Pharmanovia for exclusive commercialization rights of BupiZenge in Europe, the Middle...